| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RRM2B mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1557502 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RRM2B mRNA | CTD | PMID:21570461 |
| 2-acetamidofluorene | increases expression | ISO | RGD:1314438 | 6480464 | 2-Acetylaminofluorene results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| 2-butoxyethanol | decreases expression | ISO | RGD:1557502 | 6480464 | n-butoxyethanol results in decreased expression of RRM2B mRNA | CTD | PMID:19812364 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:1314438 | 6480464 | decitabine results in increased expression of RRM2B protein; more ... | CTD | PMID:19010910 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1314438 | 6480464 | TP53 protein affects the reaction [decitabine results in increased expression of RRM2B mRNA] | CTD | PMID:19010910 |
| 5-azacytidine | increases expression | ISO | RGD:1314438 | 6480464 | Azacitidine results in increased expression of RRM2B mRNA | CTD | PMID:19010910 |
| 5-fluorouracil | increases expression | ISO | RGD:1314438 | 6480464 | Fluorouracil results in increased expression of RRM2B mRNA | CTD | PMID:16557594 |
| 5-fluorouracil | increases expression | ISO | RGD:1314438 | 6480464 | Fluorouracil results in increased expression of RRM2B mRNA | CTD | PMID:16557594 PMID:21704725 |
| 5-fluorouracil | multiple interactions | ISO | RGD:1314438 | 6480464 | TP53 protein affects the reaction [Fluorouracil results in increased expression of RRM2B mRNA] | CTD | PMID:15016801 |
| 5-fluorouracil | decreases response to substance | ISO | RGD:1314438 | 6480464 | RRM2B protein results in decreased susceptibility to Fluorouracil | CTD | PMID:15890238 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:1314438 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| aflatoxin B1 | affects expression | ISO | RGD:1314438 | 6480464 | Aflatoxin B1 affects the expression of RRM2B protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | ISO | RGD:1314438 | 6480464 | Aflatoxin B1 results in increased expression of RRM2B mRNA | CTD | PMID:21632981 more ... |
| aflatoxin B1 | increases expression | ISO | RGD:1314438 | 6480464 | Aflatoxin B1 results in increased expression of RRM2B mRNA | CTD | PMID:21632981 more ... |
| aflatoxin B1 | increases expression | ISO | RGD:1314438 | 6480464 | Aflatoxin B1 results in increased expression of RRM2B mRNA | CTD | PMID:21641981 |
| aflatoxin B1 | increases expression | ISO | RGD:1557502 | 6480464 | Aflatoxin B1 results in increased expression of RRM2B mRNA | CTD | PMID:19770486 |
| arsenic atom | decreases expression | ISO | RGD:1557502 | 6480464 | Arsenic results in decreased expression of RRM2B mRNA | CTD | PMID:19654921 |
| benzo[a]pyrene | increases expression | ISO | RGD:1314438 | 6480464 | Benzo(a)pyrene results in increased expression of RRM2B mRNA | CTD | PMID:20064835 PMID:20106945 |
| benzo[a]pyrene | increases expression | ISO | RGD:1314438 | 6480464 | Benzo(a)pyrene metabolite results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| benzo[a]pyrene | increases expression | ISO | RGD:1314438 | 6480464 | Benzo(a)pyrene results in increased expression of RRM2B mRNA | CTD | PMID:20064835 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:1314438 | 6480464 | Benzo(a)pyrene results in increased expression of RRM2B mRNA | CTD | PMID:20064835 more ... |
| benzo[a]pyrene | affects expression | ISO | RGD:1314438 | 6480464 | Benzo(a)pyrene affects the expression of RRM2B mRNA | CTD | PMID:21873647 |
| benzo[a]pyrene | increases expression | ISO | RGD:1314438 | 6480464 | Benzo(a)pyrene results in increased expression of RRM2B mRNA | CTD | PMID:20106945 PMID:20064835 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1557502 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of RRM2B mRNA | CTD | PMID:21715664 |
| chloramphenicol | increases expression | ISO | RGD:1314438 | 6480464 | Chloramphenicol results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| cisplatin | multiple interactions | ISO | RGD:1314438 | 6480464 | [Cisplatin co-treated with 3-aminopyridine-2-carboxaldehyde thiosemicarbazone] results in increased expression of RRM2B protein | CTD | PMID:20954859 |
| cisplatin | increases expression | ISO | RGD:1314438 | 6480464 | Cisplatin results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| cisplatin | increases expression | ISO | RGD:1557502 | 6480464 | Cisplatin results in increased expression of RRM2B mRNA | CTD | PMID:21151649 |
| cisplatin | multiple interactions | ISO | RGD:1314438 | 6480464 | TP53 affects the reaction [Cisplatin results in increased expression of RRM2B protein] | CTD | PMID:21875941 |
| cisplatin | increases expression | ISO | RGD:1314438 | 6480464 | Cisplatin results in increased expression of RRM2B protein | CTD | PMID:21875941 |
| clofibrate | multiple interactions | ISO | RGD:1557502 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of RRM2B mRNA; more ... | CTD | PMID:17585979 |
| cyclophosphamide | increases expression | ISO | RGD:1314438 | 6480464 | Cyclophosphamide metabolite results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| cyclosporin A | increases expression | ISO | RGD:1314438 | 6480464 | Cyclosporine results in increased expression of RRM2B mRNA | CTD | PMID:20106945 |
| diethanolamine | increases expression | ISO | RGD:1314438 | 6480464 | diethanolamine results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| doxorubicin | increases expression | ISO | RGD:1314438 | 6480464 | Doxorubicin results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| etoposide | increases expression | ISO | RGD:1314438 | 6480464 | Etoposide results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| eugenol | increases expression | ISO | RGD:1314438 | 6480464 | Eugenol results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| genistein | increases expression | ISO | RGD:1314438 | 6480464 | Genistein results in increased expression of RRM2B mRNA | CTD | PMID:18847459 |
| hydroxyurea | increases expression | ISO | RGD:1314438 | 6480464 | Hydroxyurea results in increased expression of RRM2B mRNA | CTD | PMID:18647660 |
| isobutyraldehyde | increases expression | ISO | RGD:1314438 | 6480464 | isobutyraldehyde results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| methyl methanesulfonate | increases expression | ISO | RGD:1314438 | 6480464 | Methyl Methanesulfonate results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| morphine | increases expression | ISO | RGD:1557502 | 6480464 | Morphine results in increased expression of RRM2B mRNA | CTD | PMID:21178816 |
| N-ethyl-N-nitrosourea | increases expression | ISO | RGD:1314438 | 6480464 | Ethylnitrosourea results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | ISO | RGD:1314438 | 6480464 | Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| N-nitrosodimethylamine | increases expression | ISO | RGD:1314438 | 6480464 | Dimethylnitrosamine metabolite results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| paclitaxel | increases expression | ISO | RGD:1314438 | 6480464 | Paclitaxel results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |
| paracetamol | multiple interactions | ISO | RGD:1557502 | 6480464 | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RRM2B mRNA] | CTD | PMID:17585979 |
| paracetamol | increases expression | ISO | RGD:1314438 | 6480464 | Acetaminophen results in increased expression of RRM2B mRNA | CTD | PMID:22230336 |
| quercetin | increases expression | ISO | RGD:1314438 | 6480464 | Quercetin results in increased expression of RRM2B mRNA | CTD | PMID:21632981 |
| resveratrol | increases expression | ISO | RGD:1314438 | 6480464 | resveratrol results in increased expression of RRM2B mRNA | CTD | PMID:15767336 |
| trans-resveratrol | increases expression | ISO | RGD:1314438 | 6480464 | resveratrol results in increased expression of RRM2B mRNA | CTD | PMID:15767336 |
| valproic acid | increases expression | ISO | RGD:1314438 | 6480464 | Valproic Acid results in increased expression of RRM2B mRNA | CTD | PMID:19101580 |
| zebularine | increases expression | ISO | RGD:1314438 | 6480464 | pyrimidin-2-one beta-ribofuranoside results in increased expression of RRM2B mRNA | CTD | PMID:19010910 |
| zidovudine | increases expression | ISO | RGD:1314438 | 6480464 | Zidovudine results in increased expression of RRM2B mRNA | CTD | PMID:21704725 |